Petros Skapinakis

Prof. Petros Skapinakis

Department of Psychiatry, School of Medicine, University of Ioannina, 70121 Ioannina, Greece
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in The Lancet Psychiatry
Verified
Journal Article
Open access
Petros SkapinakisPetros Skapinakis
Petros Skapinakis
DCDeborah M Caldwell
Deborah M Caldwell
WHWilliam Hollingworth
William Hollingworth
PBPeter Bryden
Peter Bryden
NFNaomi A Fineberg
Naomi A Fineberg
GLGlyn Lewis
Glyn Lewis
Several interventions are available for management of obsessive-compulsive disorder in adults, but few studies have compared their relative efficacy in a single analysis. We aimed to simultaneously compare all available treatments using both direct and indirect data. In this systematic review and network meta-analysis, we searched the two controlled trials registers maintained by the Cochrane Collaboration Common Mental Disorders group for trials published up to Feb 16, 2016. We selected randomised controlled trials in which an active psychotherapeutic or pharmacological intervention had been used in adults with obsessive-compulsive disorder. We allowed all comorbidities except for schizophrenia or bipolar disorder. We excluded studies that focused exclusively on treatment-resistant patient populations defined within the same study. We extracted data from published reports. The primary outcome was symptom severity as measured by the Yale-Brown Obsessive Compulsive Scale. We report mean differences with 95% credible intervals compared with placebo. This study is registered with PROSPERO, number CRD42012002441. We identified 1480 articles in our search and included 53 articles (54 trials; 6652 participants) in the network meta-analysis. Behavioural therapy (mean difference -14·48 [95% credible interval -18·61 to -10·23]; 11 trials and 287 patients), cognitive therapy (-13·36 [-18·40 to -8·21]; six trials and 172 patients), behavioural therapy and clomipramine (-12·97 [-19·18 to -6·74]; one trial and 31 patients), cognitive behavioural therapy and fluvoxamine (-7·50 [-13·89 to -1·17]; one trial and six patients), cognitive behavioural therapy (-5·37 [-9·10 to -1·63]; nine trials and 231 patients), clomipramine (-4·72 [-6·85 to -2·60]; 13 trials and 831 patients), and all SSRIs (class effect -3·49 [95% credible interval -5·12 to -1·81]; 37 trials and 3158 patients) had greater effects than did drug placebo. Clomipramine was not better than were SSRIs (-1·23 [-3·41 to 0·94]). Psychotherapeutic interventions had a greater effect than did medications, but a serious limitation was that most psychotherapeutic trials included patients who were taking stable doses of antidepressants (12 [80%] of the 15 psychotherapy trials explicitly allowed antidepressants). A range of interventions is effective in the management of obsessive-compulsive disorder, but considerable uncertainty and limitations exist regarding their relative efficacy. Taking all the evidence into account, the combination of psychotherapeutic and psychopharmacological interventions is likely to be more effective than are psychotherapeutic interventions alone, at least in severe obsessive-compulsive disorder. National Institute for Health Research.

1 January 2011 in The American Journal of Surgery
Verified
Journal Article
Closed access
RKReenam S. Khan
Reenam S. Khan
KAKamran Ahmed
Kamran Ahmed
EBElizabeth Blakeway
Elizabeth Blakeway
Petros SkapinakisPetros Skapinakis
Petros Skapinakis
LNLeo Nihoyannopoulos
Leo Nihoyannopoulos
TAThanos Athanasiou
Thanos Athanasiou

1 November 2009 in Pain Medicine
Verified
Journal Article
Open access
PDF file
MPMarianna Papaioannou
Marianna Papaioannou
Petros SkapinakisPetros Skapinakis
Petros Skapinakis
DDDimitris Damigos
Dimitris Damigos
VMVenetsanos Mavreas
Venetsanos Mavreas
GBGeorgios Broumas
Georgios Broumas
APAndroniki Palgimesi
Androniki Palgimesi
Objective. Catastrophizing has been broadly conceived as an exaggerated negative “mental set” brought to bear during actual or anticipated pain experi

1 October 2007 in BMJ Evidence-Based Medicine
Verified
Journal Article
Open access
PDF file
Petros SkapinakisPetros Skapinakis
Petros Skapinakis
Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ GP/FP/Mental health ★★★★★★☆ Psychiatry ★★★★★☆☆

2 March 2009 in Drug and Alcohol Review
Verified
Journal Article
Closed access
PDF file
JDJames Z. Daniel
James Z. Daniel
MHMatthew Hickman
Matthew Hickman
JMJohn Macleod
John Macleod
NWNicola Wiles
Nicola Wiles
ALAnne Lingford‐Hughes
Anne Lingford‐Hughes
GLGlyn Lewis
Glyn Lewis

1 January 2016 in Annals of Surgery
Verified
Journal Article
Closed access
EMErik K. PhD Mayer
Erik K. PhD Mayer
NSNick Sevdalis
Nick Sevdalis
SRShantanu Mrcs Rout
Shantanu Mrcs Rout
JCJochem Mrcs Caris
Jochem Mrcs Caris
SRStephanie Russ
Stephanie Russ
ADAra FACS Darzi
Ara FACS Darzi
Objective: To evaluate impact of WHO checklist compliance on risk-adjusted clinical outcomes, including the influence of checklist components (Sign-in, Time-out, Sign-out) on outcomes. Background: There remain unanswered questions surrounding surgical checklists as a quality and safety tool, such as the impact in cases of differing complexity and the extent of checklist implementation. Methods: Data were collected from surgical admissions (6714 patients) from March 2010 to June 2011 at 5 academic and community hospitals. The primary endpoint was any complication, including mortality, occurring before hospital discharge. Checklist usage was recorded as checklist completed in full/partly. Multilevel modeling was performed to investigate the association between complications/mortality and checklist completion. Results: Significant variability in checklist usage was found: although at least 1 of the 3 components was completed in 96.7% of cases, the entire checklist was only completed in 62.1% of cases. Checklist completion did not affect mortality reduction, but significantly lowered risk of postoperative complication (16.9% vs. 11.2%), and was largely noticed when all 3 components of the checklist had been completed (odds ratio = 0.57, 95% confidence interval: 0.37–0.87, P < 0.01). Calculated population-attributable fractions showed that 14% (95% confidence interval: 7%-21%) of the complications could be prevented if full completion of the checklist was implemented. Conclusions: Checklist implementation was associated with reduced case-mix-adjusted complications after surgery and was most significant when all 3 components of the checklist were completed. Full, as opposed to partial, checklist completion provides a health policy opportunity to improve checklist impact on surgical safety and quality of care.